• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人因子II(前凝血酶原和凝血酶原)的产后发育

Post-natal development of factor II (pre-prothrombin and prothrombin) in man.

作者信息

Schettini F, de Mattia D, Mautone A, Altomare M

出版信息

Biol Neonate. 1976;29(1-2):82-8. doi: 10.1159/000240851.

DOI:10.1159/000240851
PMID:1276302
Abstract

Postnatal development of factor II molecule has been evaluated by three different methods in infants and children from 15 days to 7 years of age. The immunochemical determination of factor II showed that the plasma levels of this factor reached the lowest adult values between 4-7 months of age and rose slowly for all the first year; after this age the plasma concentration was steady. The adult range was reached from 15 to 120 days of age when the factor II was evaluated by the method of Owren and Aas (19) and by staphylocoagulase reagent.

摘要

采用三种不同方法对15天至7岁婴幼儿及儿童体内凝血因子II分子的产后发育情况进行了评估。凝血因子II的免疫化学测定结果显示,该因子的血浆水平在4至7个月龄时降至成人最低值,并在出生后的第一年缓慢上升;此后血浆浓度保持稳定。当采用奥伦和阿斯(19)的方法以及葡萄球菌凝固酶试剂评估凝血因子II时,15至120日龄时达到成人范围。

相似文献

1
Post-natal development of factor II (pre-prothrombin and prothrombin) in man.人因子II(前凝血酶原和凝血酶原)的产后发育
Biol Neonate. 1976;29(1-2):82-8. doi: 10.1159/000240851.
2
Prothrombin and protein C in early childhood: normal adult levels are not achieved until the fourth year of life.幼儿期的凝血酶原和蛋白C:直到4岁时才能达到正常成人水平。
J Pediatr. 1986 Nov;109(5):843-5. doi: 10.1016/s0022-3476(86)80708-9.
3
Prothrombin antigen and coagulant activity in patients with liver disease.肝病患者的凝血酶原抗原及凝血活性
JAMA. 1982 Oct 8;248(14):1736-9.
4
Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.口服抗凝治疗早期和稳定期国际标准化比值、维生素K依赖凝血因子水平与体内凝血酶原激活之间的关系
Haematologica. 2002 Oct;87(10):1074-80.
5
Development of selected coagulation factors and anticoagulants in preterm infants by the age of six months.
Thromb Haemost. 2004 Oct;92(4):688-96. doi: 10.1160/TH03-12-0769.
6
[Photometric and immunologic determination of prothrombin (blood coagulation factor II) in plasma].[血浆中凝血酶原(血液凝固因子II)的光度法和免疫法测定]
Z Med Lab Diagn. 1987;28(4):199-206.
7
Acarboxy prothrombin (PIVKA-II) in cord plasma in the south of Thailand.泰国南部脐带血血浆中的脱γ-羧基凝血酶原(异常凝血酶原-II)
J Med Assoc Thai. 1993 May;76(5):278-84.
8
The association between prenatal and or post natal growth disorder and lipid profile in adolescents aged 12 - 15 years old in Tanjungsari Subdistrict, Sumedang, West Java.西爪哇省苏梅当县坦容萨里分区12至15岁青少年的产前和产后生长障碍与血脂水平之间的关联。
Acta Med Indones. 2005 Jul-Sep;37(3):149-56.
9
Pre-natal and post-natal growth trajectories and childhood cognitive ability and mental health.产前和产后生长轨迹与儿童认知能力和心理健康。
Int J Epidemiol. 2011 Oct;40(5):1215-26. doi: 10.1093/ije/dyr094. Epub 2011 Jul 15.
10
Use of chromogenic peptide substrates in the determination of clotting factors II, VII, IX and X in normal plasma and in plasma of patients treated with oral anticoagulants.生色肽底物在正常血浆及口服抗凝剂治疗患者血浆中凝血因子II、VII、IX和X测定中的应用。
Haemostasis. 1982;12(3):241-55. doi: 10.1159/000214679.

引用本文的文献

1
Physiological activation of plasminogen in full term newborn infants.足月新生儿纤溶酶原的生理激活
J Clin Pathol. 1984 Nov;37(11):1264-7. doi: 10.1136/jcp.37.11.1264.